Skip to main content

Table 1 Patients' clinical and pathological characteristics

From: Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer

Variable

Subgroup

n(%)

age (years)

≤ 65

31 (44.3)

range 47-75

> 65

39 (55.7)

pre-op PSA (ng/ml)

< 5

14 (20.0)

range 2.8-23.9

5-10

48 (68.6)

 

> 10

8 (11.4)

pT stage

≤ 2

42 (60.0)

 

> 2

28 (40.0)

Gleason score

≤ 7 (3+4)

50 (46.8)

 

≥ 7 (4+3)

20 (44.2)

  1. pre-op PSA, pre-operative PSA; pT stage, pathologic TNM stage